Valsartan
Product Images NDC 45865-101

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 45865-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp_101 (Pdp 101)

Description: This is a label for a container of Valsartan tablets. The details include the dosage (80mg), the manufacturer (Sjubricant Generics Ltd), and precautions to be taken before using the product.*

FDA Label Image

Figure01 (Fig01)

This is a clinical study that compares the effectiveness of Valsartan and Captopril in treating patients. The study evaluates subgroups such as age (<65 years old and 65+), gender (male and female), ethnicity (Caucasian and non-Caucasian), country of origin (US and Non-US), and usage of Beta-blocker. The effectiveness of each medication is reported in percentage, with Favors Valsartan being more effective in some cases and Favors Captopril being more effective in others.*

FDA Label Image

Structuralformula (Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.